a public good project by the
Synthesis
Company
of California

© 2026

Juan J. Gómez‐Reino | doi.page

0 works0 citations0 h-index

Juan J. Gómez‐Reino

Hospital Clínico Universitario de Valencia(ES)Complejo Hospitalario Universitario de Santiago(ES)

Publications by Year

Research Areas

Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Autoimmune and Inflammatory Disorders Research, Monoclonal and Polyclonal Antibodies Research, Chronic Lymphocytic Leukemia Research

Most-Cited Works

→ EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update(2017)5,757 cited
→ Treating rheumatoid arthritis to target: recommendations of an international task force(2010)2,076 cited
→ \nEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.(2010)1,620 cited
→ Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force(2015)1,431 cited
→ American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials(2011)1,015 cited
→ Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active‐surveillance report

(2003)

1,011 cited

→ Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis(2010)858 cited

→ Interleukin‐6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease‐modifying antirheumatic drugs: The tocilizumab in combination with traditional disease‐modifying antirheumatic drug therapy study(2008)855 cited

→ Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study(2009)804 cited